rs372125621

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_016239.4(MYO15A):​c.2462A>C​(p.Gln821Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00586 in 1,451,342 control chromosomes in the GnomAD database, including 178 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.020 ( 76 hom., cov: 32)
Exomes 𝑓: 0.0043 ( 102 hom. )

Consequence

MYO15A
NM_016239.4 missense

Scores

1
1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: -0.0760

Publications

2 publications found
Variant links:
Genes affected
MYO15A (HGNC:7594): (myosin XVA) This gene encodes an unconventional myosin. This protein differs from other myosins in that it has a long N-terminal extension preceding the conserved motor domain. Studies in mice suggest that this protein is necessary for actin organization in the hair cells of the cochlea. Mutations in this gene have been associated with profound, congenital, neurosensory, nonsyndromal deafness. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Read-through transcripts containing an upstream gene and this gene have been identified, but they are not thought to encode a fusion protein. Several alternatively spliced transcript variants have been described, but their full length sequences have not been determined. [provided by RefSeq, Jul 2008]
MYO15A Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025024116).
BP6
Variant 17-18121262-A-C is Benign according to our data. Variant chr17-18121262-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 226781.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0565 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO15ANM_016239.4 linkc.2462A>C p.Gln821Pro missense_variant Exon 2 of 66 ENST00000647165.2 NP_057323.3 Q9UKN7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO15AENST00000647165.2 linkc.2462A>C p.Gln821Pro missense_variant Exon 2 of 66 NM_016239.4 ENSP00000495481.1 Q9UKN7-1
MYO15AENST00000583079.1 linkn.2095A>C non_coding_transcript_exon_variant Exon 1 of 1 6

Frequencies

GnomAD3 genomes
AF:
0.0196
AC:
2947
AN:
150706
Hom.:
76
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0583
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0121
Gnomad ASJ
AF:
0.0121
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00415
Gnomad FIN
AF:
0.00197
Gnomad MID
AF:
0.0417
Gnomad NFE
AF:
0.00342
Gnomad OTH
AF:
0.0179
GnomAD2 exomes
AF:
0.00544
AC:
386
AN:
70928
AF XY:
0.00524
show subpopulations
Gnomad AFR exome
AF:
0.0559
Gnomad AMR exome
AF:
0.00472
Gnomad ASJ exome
AF:
0.0117
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00125
Gnomad NFE exome
AF:
0.00391
Gnomad OTH exome
AF:
0.0148
GnomAD4 exome
AF:
0.00426
AC:
5541
AN:
1300528
Hom.:
102
Cov.:
36
AF XY:
0.00416
AC XY:
2669
AN XY:
641502
show subpopulations
African (AFR)
AF:
0.0741
AC:
1895
AN:
25574
American (AMR)
AF:
0.00589
AC:
152
AN:
25826
Ashkenazi Jewish (ASJ)
AF:
0.0113
AC:
243
AN:
21594
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26928
South Asian (SAS)
AF:
0.00430
AC:
310
AN:
72126
European-Finnish (FIN)
AF:
0.000976
AC:
32
AN:
32784
Middle Eastern (MID)
AF:
0.0362
AC:
139
AN:
3842
European-Non Finnish (NFE)
AF:
0.00221
AC:
2299
AN:
1038678
Other (OTH)
AF:
0.00886
AC:
471
AN:
53176
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
279
558
838
1117
1396
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0196
AC:
2957
AN:
150814
Hom.:
76
Cov.:
32
AF XY:
0.0191
AC XY:
1410
AN XY:
73706
show subpopulations
African (AFR)
AF:
0.0584
AC:
2412
AN:
41288
American (AMR)
AF:
0.0121
AC:
183
AN:
15164
Ashkenazi Jewish (ASJ)
AF:
0.0121
AC:
42
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5120
South Asian (SAS)
AF:
0.00457
AC:
22
AN:
4816
European-Finnish (FIN)
AF:
0.00197
AC:
20
AN:
10146
Middle Eastern (MID)
AF:
0.0342
AC:
10
AN:
292
European-Non Finnish (NFE)
AF:
0.00342
AC:
231
AN:
67528
Other (OTH)
AF:
0.0177
AC:
37
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
139
279
418
558
697
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0142
Hom.:
7
ESP6500AA
AF:
0.0351
AC:
70
ESP6500EA
AF:
0.00172
AC:
8
ExAC
AF:
0.00260
AC:
128
Asia WGS
AF:
0.00897
AC:
30
AN:
3358

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:4
Feb 26, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 05, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 30, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Gln821Pro in Exon 02 of MYO15A: This variant is not expected to have clinical significance because it has been identified in 3.7% (56/1508) of African America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS). -

Autosomal recessive nonsyndromic hearing loss 3 Uncertain:1Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
15
DANN
Benign
0.80
DEOGEN2
Benign
0.019
T;T;T
Eigen
Benign
-0.93
Eigen_PC
Benign
-0.82
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.42
T;.;T
MetaRNN
Benign
0.0025
T;T;T
MetaSVM
Benign
-0.79
T
MutationAssessor
Benign
0.0
.;N;N
PhyloP100
-0.076
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-0.72
.;N;.
REVEL
Benign
0.18
Sift
Uncertain
0.0030
.;D;.
Sift4G
Benign
0.18
T;T;.
Polyphen
0.0
.;B;B
Vest4
0.21
MVP
0.60
ClinPred
0.0081
T
GERP RS
2.0
Varity_R
0.13
gMVP
0.32
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs372125621; hg19: chr17-18024576; COSMIC: COSV52754982; API